FEATURES OF PURINE METABOLISM AND MICROALBUMINURIA OF ISCHEMIC HEART DISEASE IN PATIENTS WITH METABOLIC SYNDROME

Authors

  • Tashtemirova I. M Andijan State Medical Institute
  • Qosimov I.S Andijan State Medical Institute

Keywords:

Metabolism And Microalbuminuria, Metabolic syndrome

Abstract

To study the state of purine metabolism and microalbuminuria in patients with metabolic syndrome

References

Arutyunov G. P. Diabetes mellitus and atherosclerosis. What is the optimal strategy for controlling the atherosclerotic process? Heart. 2014; 3 (1): 36

Alieva A.M. Possibilities of drug correction of metabolic disorders and prevention of diabetes mellitus in cases of carbohydrate metabolism disorders. Medical business. 2015; 3: 59–65.

Donskov A. S., Dadina Z. M., Golub ' G. V. et al. Disorders of purine metabolism in patients with arterial hypertension. Cardiology. 2018; 10: From 41-47.

Kobalova Zh. D., Tolkacheva V. V., Karaulova Yu. L. Uric¬acid is a marker and / or a new risk factor for the development of cardiovascular¬complications. Rus med zhurnal 2017; 10: P 431-436.

Kuzaeva F. M. et al. Current understanding of the factors that cause¬kidney damage in gout. // Ter. archive 2019; 5: From 90-95.

Keren M. A., Yarbekov R. R. Current state and prospects of development of coronary revascularization in patients with diabetes mellitus. Bulletin of the A. N. Bakulev National Center of Agriculture of the Russian Academy of Medical Sciences. 2015; 16 (1): 4-13.

Madyanov I. V., Balabolkin M. I., Grigoriev A. A., Markov D.¬Hyperuricemia as a component of metabolic syndrome X. Prob endocrinol; 6: from 30-32.

Tashkenbayeva E. N. Hyperuricemia in the mechanisms¬of development of metabolic syndrome and cardiovascular complications. Med. Journal¬of Uzbekistan 2006, No. 4, pp. 91-95

Khurs E. M., Andreev P. V., Poddubnaya A.V. et al. Vegetative imbalance in the pathogenesis of metabolic syndrome. Clinical medicine. 2020; 88 (6): 39–42.

Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014; 31: 2501–55.

Bleyer A.J. et al. Renal manifest factions of a mutation in the uromodium (Tamm Horsfall protein) gene. Amer J kidney Dis. 2017;42: P20-26.

Downloads

Published

2024-03-30

How to Cite

Tashtemirova I. M, & Qosimov I.S. (2024). FEATURES OF PURINE METABOLISM AND MICROALBUMINURIA OF ISCHEMIC HEART DISEASE IN PATIENTS WITH METABOLIC SYNDROME. World Bulletin of Public Health, 32, 192-195. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/4000

Issue

Section

Articles